Hot Stocks: Brokerage view on Apollo Hospitals, HEG, Tata Chemicals, Indigo and Dalmia Bharat

June 15, 2023

JPMorgan has started coverage of Apollo Hospitals as overweight, with a target price of INR 5,950 ($80). The bank has started coverage of Fortis Healthcare as overweight, with a INR 355 target. Morgan Stanley downgraded Tata Chemicals to equal-weight, downgraded its target price to INR 916 and maintained an overweight rating on Indigo with a target price of INR 3,126. Furthermore, InCred began covering HEG with an ‘add’ rating and expects it to trend upwards due to reduced US steel inventory levels. Jefferies maintained a buy rating on Dalmia Bharat with a target price of INR 2,490.

More To Explore

Sugar stocks rally continues: Balrampur Chini, Dhampur Sugar, Uttam Sugar Mills rally up to 4%. Two big triggers

Sugar stocks rallied as domestic sugar prices surged sharply over the past month. Government data showed retail prices rising from Rs 48.18/kg on July 20

August 28, 2026

Yatharth Hospital shares jump 5% as Aster, Advent likely eye controlling stake

Yatharth Hospital shares jumped over 5% after reports that Aster DM Quality Care, backed by Advent International and Blackstone, is negotiating to acquire a controlling

August 28, 2026

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

The information on this website does not constitute investment advice or a recommendation or a solicitation to engage in any investment activity. This website and its content are not intended for residents of the UAE, US, Canada, Australia, UK, Russia, North Korea, China, Japan, Hong Kong, Singapore and Iran.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003